Deep Track Capital, LP
- SEC CIK
- 0001856083
- 最新申報
- 2026/8/14
2023 年第 3 季持倉
持倉截至 2023/9/30，2023/11/14 申報。只含多頭部位，變化是跟 2023 年第 2 季比股數。
- 持股檔數
- 62
- 較 2023 年第 2 季 +9
- 總值
- $25.8 億
- 較 2023 年第 2 季 +$4.38 億 (+20.4%)
| 證券 | 類別 | 股數 | 市值 | 佔組合 % | 股數變化 | 動作 | 紀錄 |
|---|---|---|---|---|---|---|---|
| INSMINSMED Inc | COM PAR $.01 | 6,000,000 | $1.51 億 | 5.9% | −500,000−7.7% | 減碼 | 歷史 |
| JAZZJazz Pharmaceuticals plc | SHS USD | 1,138,045 | $1.47 億 | 5.7% | −111,955−9.0% | 減碼 | 歷史 |
| ITCIIntra-Cellular Therapies, Inc. | COM | 2,600,000 | $1.35 億 | 5.3% | +1,051,748+67.9% | 加碼 | 歷史 |
| IONSIonis Pharmaceuticals Inc | COM | 2,834,069 | $1.29 億 | 5.0% | 00.0% | 不變 | 歷史 |
| GHGuardant Health, Inc. | COM | 4,050,000 | $1.20 億 | 4.7% | +2,550,000+170.0% | 加碼 | 歷史 |
| IMVTImmunovant, Inc. | COM | 2,797,955 | $1.07 億 | 4.2% | −2,623,375−48.4% | 減碼 | 歷史 |
| ALKSAlkermes plc. | SHS | 3,800,000 | $1.06 億 | 4.1% | +800,000+26.7% | 加碼 | 歷史 |
| DVAXDynavax Technologies Corp | COM NEW | 6,756,956 | $9,980 萬 | 3.9% | +199,140+3.0% | 加碼 | 歷史 |
| GPCRStructure Therapeutics Inc. | SPONSORED ADS | 1,915,000 | $9,655 萬 | 3.7% | −731,782−27.6% | 減碼 | 歷史 |
| PLRXPliant Therapeutics, Inc. | COM | 5,500,000 | $9,537 萬 | 3.7% | +1,450,000+35.8% | 加碼 | 歷史 |
| SWTXSpringWorks Therapeutics, Inc. | COM | 3,546,435 | $8,199 萬 | 3.2% | 00.0% | 不變 | 歷史 |
| AXSMAxsome Therapeutics, Inc. | COM | 1,140,745 | $7,973 萬 | 3.1% | +756,545+196.9% | 加碼 | 歷史 |
| BCYCBicycle Therapeutics PLC | SPONSORED ADS | 3,490,506 | $7,012 萬 | 2.7% | +671,461+23.8% | 加碼 | 歷史 |
| TVTXTravere Therapeutics, Inc. | COM | 7,370,000 | $6,589 萬 | 2.6% | 00.0% | 不變 | 歷史 |
| NTLAIntellia Therapeutics, Inc. | COM | 2,000,000 | $6,324 萬 | 2.5% | +1,164,554+139.4% | 加碼 | 歷史 |
| EDITEditas Medicine, Inc. | COM | 7,101,935 | $5,540 萬 | 2.1% | +3,648,191+105.6% | 加碼 | 歷史 |
| GERNGeron Corp | COM | 25,700,000 | $5,448 萬 | 2.1% | +1,529,034+6.3% | 加碼 | 歷史 |
| VRNAVerona Pharma plc | SPONSORED ADS | 3,187,415 | $5,195 萬 | 2.0% | 00.0% | 不變 | 歷史 |
| APGEApogee Therapeutics, Inc. | COM | 2,414,373 | $5,143 萬 | 2.0% | +2,414,373 | 新進 | 歷史 |
| PACBPacific Biosciences of California, Inc. | COM | 6,000,000 | $5,010 萬 | 1.9% | +4,548,799+313.5% | 加碼 | 歷史 |
| VRDNViridian Therapeutics, Inc. | COM | 2,963,267 | $4,546 萬 | 1.8% | +1,683,765+131.6% | 加碼 | 歷史 |
| NVCRNovoCure Ltd | ORD SHS | 2,500,000 | $4,038 萬 | 1.6% | +2,500,000 | 新進 | 歷史 |
| HLVXHilleVax, Inc. | COM | 2,900,000 | $3,901 萬 | 1.5% | +2,900,000 | 新進 | 歷史 |
| RPTXRepare Therapeutics Inc. | COM | 3,067,731 | $3,706 萬 | 1.4% | +340,125+12.5% | 加碼 | 歷史 |
| AGENAgenus Inc | COM NEW | 31,697,539 | $3,582 萬 | 1.4% | +1,697,539+5.7% | 加碼 | 歷史 |
| FDMT4D Molecular Therapeutics, Inc. | COM | 2,778,107 | $3,537 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| AUTLAutolus Therapeutics plc | SPON ADS | 15,000,000 | $3,495 萬 | 1.4% | 00.0% | 不變 | 歷史 |
| NBIXNeurocrine Biosciences Inc | Stock | 300,000 | $3,375 萬 | 1.3% | +300,000 | 新進 | 歷史 |
| TERNTerns Pharmaceuticals, Inc. | COM | 6,000,000 | $3,018 萬 | 1.2% | +4,900,808+445.9% | 加碼 | 歷史 |
| RAPTRAPT Therapeutics, Inc. | COM | 1,500,000 | $2,493 萬 | 1.0% | +495,439+49.3% | 加碼 | 歷史 |
| BEAMBeam Therapeutics Inc. | COM | 1,015,641 | $2,443 萬 | 0.9% | −301,675−22.9% | 減碼 | 歷史 |
| ANABAnaptysbio, Inc | COM | 1,345,813 | $2,417 萬 | 0.9% | +1,345,813 | 新進 | 歷史 |
| OLMAOlema Pharmaceuticals, Inc. | COM | 1,930,894 | $2,385 萬 | 0.9% | +1,930,894 | 新進 | 歷史 |
| NRIXNurix Therapeutics, Inc. | COM | 2,997,830 | $2,356 萬 | 0.9% | 00.0% | 不變 | 歷史 |
| ANIPAni Pharmaceuticals Inc | COM | 400,000 | $2,322 萬 | 0.9% | −114,021−22.2% | 減碼 | 歷史 |
| AMLXAmylyx Pharmaceuticals, Inc. | COM | 1,259,335 | $2,306 萬 | 0.9% | +1,259,335 | 新進 | 歷史 |
| BNTXBioNTech SE | SPONSORED ADS | 200,000 | $2,173 萬 | 0.8% | +200,000 | 新進 | 歷史 |
| DYNDyne Therapeutics, Inc. | COM | 2,403,672 | $2,154 萬 | 0.8% | −96,240−3.8% | 減碼 | 歷史 |
| MRNAModerna, Inc. | Stock | 200,000 | $2,066 萬 | 0.8% | +200,000 | 新進 | 歷史 |
| SLNSilence Therapeutics plc | ADS | 1,951,580 | $1,916 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| PNTPOINT Biopharma Global Inc. | COM | 2,781,565 | $1,855 萬 | 0.7% | 00.0% | 不變 | 歷史 |
| ZURAZura Bio Ltd | CLASS A ORD SHS | 2,523,000 | $1,665 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| ORTXOrchard Therapeutics plc | SPON ADS NEW | 2,041,670 | $1,578 萬 | 0.6% | +2,041,670 | 新進 | 歷史 |
| EWTXEdgewise Therapeutics, Inc. | COM | 2,750,000 | $1,576 萬 | 0.6% | 00.0% | 不變 | 歷史 |
| NKTRNektar Therapeutics | COM | 18,400,000 | $1,096 萬 | 0.4% | +426,536+2.4% | 加碼 | 歷史 |
| MORFMorphic Holding, Inc. | COM | 470,647 | $1,078 萬 | 0.4% | +253,895+117.1% | 加碼 | 歷史 |
| AGIOAgios Pharmaceuticals, Inc. | COM | 422,247 | $1,045 萬 | 0.4% | +422,247 | 新進 | 歷史 |
| ABOSAcumen Pharmaceuticals, Inc. | COM | 2,513,044 | $1,043 萬 | 0.4% | −1,403,317−35.8% | 減碼 | 歷史 |
| NUVBNuvation Bio Inc. | COM CL A | 7,720,688 | $1,035 萬 | 0.4% | 00.0% | 不變 | 歷史 |
| VIGLVigil Neuroscience, Inc. | COM | 1,767,131 | $952.5 萬 | 0.4% | −6,278−0.4% | 減碼 | 歷史 |
| RLMDRelmada Therapeutics, Inc. | COM | 2,837,818 | $851.3 萬 | 0.3% | 00.0% | 不變 | 歷史 |
| ATXSAstria Therapeutics, Inc. | COM | 1,037,873 | $774.3 萬 | 0.3% | −659,542−38.9% | 減碼 | 歷史 |
| TXG10x Genomics, Inc. | CL A COM | 182,691 | $753.6 萬 | 0.3% | +182,691 | 新進 | 歷史 |
| NVAXNovavax Inc | COM NEW | 1,000,000 | $724.0 萬 | 0.3% | +1,000,000 | 新進 | 歷史 |
| SLRNACELYRIN, Inc. | COM | 551,289 | $560.7 萬 | 0.2% | +551,289 | 新進 | 歷史 |
| GHRSGH Research PLC | ORDINARY SHARES | 499,400 | $501.9 萬 | 0.2% | 00.0% | 不變 | 歷史 |
| SYRSSyros Pharmaceuticals, Inc. | COM NEW | 828,485 | $327.3 萬 | 0.1% | +828,485 | 新進 | 歷史 |
| SRRKScholar Rock Holding Corp | COM | 353,855 | $251.2 萬 | 0.1% | +353,855 | 新進 | 歷史 |
| CMPSCOMPASS Pathways plc | SPONSORED ADS | 328,424 | $243.0 萬 | 0.1% | −349,936−51.6% | 減碼 | 歷史 |
| HRTXHeron Therapeutics, Inc. | COM | 2,086,704 | $214.9 萬 | 0.1% | 00.0% | 不變 | 歷史 |
| ETNB89bio, Inc. | COM | 91,078 | $140.6 萬 | 0.1% | −412,022−81.9% | 減碼 | 歷史 |
| IPSCCentury Therapeutics, Inc. | COM | 543,008 | $108.6 萬 | <0.1% | −479,884−46.9% | 減碼 | 歷史 |
選擇權（1 檔）
同一份申報裡的賣權（put）與買權（call）。金額是標的股票的市值，也就是 13F 申報的數字。
| 證券 | 類別 | 賣權 | 買權 |
|---|---|---|---|
| PRTAProthena Corp Public Ltd Co | SHS | $1,206 萬 | – |
2023 年第 2 季之後清倉（7 檔）
2023 年第 2 季季末還持有、這份申報已經沒有的部位。
| 證券 | 類別 | 2023 年第 2 季股數 | 2023 年第 2 季市值 | 2023 年第 2 季佔組合 % | 紀錄 |
|---|---|---|---|---|---|
| ORTXOrchard Therapeutics plc | ADS | 2,041,670 | $1,064 萬 | 0.5% | 歷史 |
| INZYInozyme Pharma, Inc. | COM | 1,644,021 | $915.7 萬 | 0.4% | 歷史 |
| ZNTLZentalis Pharmaceuticals, Inc. | COM | 300,300 | $847.1 萬 | 0.4% | 歷史 |
| MLTXMoonLake Immunotherapeutics | CLASS A ORD | 108,450 | $553.1 萬 | 0.3% | 歷史 |
| ALLKAllakos Inc. | COM | 228,277 | $99.5 萬 | <0.1% | 歷史 |
| IMUXImmunic, Inc. | COM | 308,314 | $77.4 萬 | <0.1% | 歷史 |
| INKTMiNK Therapeutics, Inc. | COM | 324,867 | $68.2 萬 | <0.1% | 歷史 |